Common/NNP Pain/NNP Reliever/NNP Slowed/NNP Lung/NNP Decline/NNP in/IN Children/NNP With/IN Cystic/NNP Fibrosis/NNPS High/NNP doses/NNS of/IN a/DT common/JJ pain/NN reliever/NN slowed/VBD lung/NN deterioration/NN by/IN 90/CD percent/NN over/IN four/CD years/NNS in/IN children/NNS with/IN cystic/JJ fibrosis/NNS ,/, a/DT study/NN found/VBD ./.

The/DT benefits/NNS of/IN ibuprofen/NN --/: sold/VBN under/IN such/JJ brand/NN names/NNS as/IN Advil/NNP ,/, Nuprin/NNP and/CC Motrin/NNP --/: were/VBD most/RBS dramatic/JJ in/IN children/NNS ages/NNS 5/CD to/TO 13/CD who/WP consistently/RB took/VBD it/PRP twice/RB a/DT day/NN in/IN addition/NN to/TO conventional/JJ treatments/NNS with/IN other/JJ drugs/NNS ,/, the/DT study/NN 's/POS authors/NNS said/VBD ./.

Ibuprofen/NNP might/MD also/RB have/VB some/DT reduced/VBN benefit/NN in/IN older/JJR patients/NNS ,/, the/DT researchers/NNS said/VBD ./.

The/DT pain/NN reliever/NN is/VBZ sold/VBN in/IN the/DT United/NNP States/NNPS without/IN a/DT perscription/NN ./.

``/`` I/PRP think/VBP this/DT study/NN suggests/VBZ it/PRP 's/VBZ a/DT valid/JJ therapy/NN to/TO introduce/VB into/IN the/DT clinic/NN ,/, ''/'' said/VBD one/CD of/IN the/DT authors/NNS ,/, Dr./NNP Pamela/NNP Davis/NNP of/IN Rainbow/NNP Babies/NNP and/CC Childrens/NNP Hospital/NNP in/IN Cleveland/NNP ./.

The/DT study/NN appears/VBZ Thursday/NNP in/IN the/DT New/NNP England/NNP Journal/NNP of/IN Medicine/NNP ./.

Doctors/NNS agreed/VBD that/IN the/DT addition/NN of/IN the/DT new/JJ treatment/NN is/VBZ likely/JJ to/TO increase/VB the/DT life/NN expectancy/NN of/IN cystic/JJ fibrosis/NNS patients/NNS ,/, although/IN it/PRP will/MD be/VB years/NNS before/IN that/DT is/VBZ proven/VBN ./.

With/IN current/JJ treatments/NNS ,/, half/NN of/IN the/DT 1,000/CD new/JJ patients/NNS diagnosed/VBD each/DT year/NN die/VBP before/IN age/NN 30/CD ./.

Davis/NNP cautioned/VBD patients/NNS not/RB to/TO begin/VB treating/VBG themselves/PRP with/IN the/DT drug/NN ,/, because/IN it/PRP can/MD have/VB harmful/JJ side/NN effects/NNS if/IN it/PRP is/VBZ n't/RB used/VBN correctly/RB ./.

It/PRP can/MD harm/VB the/DT stomach/NN and/CC kidneys/NNS and/CC interfere/VB with/IN other/JJ drugs/NNS used/VBN to/TO treat/VB cystic/JJ fibrosis/NNS ,/, she/PRP said/VBD ./.

``/`` One/CD of/IN the/DT things/NNS we/PRP 're/VBP worried/JJ about/IN is/VBZ that/IN the/DT drug/NN is/VBZ available/JJ over/IN the/DT counter/NN ./.

We/PRP would/MD absolutely/RB not/RB suggest/VB that/IN CF/NNP patients/NNS go/VBP down/RP to/TO the/DT drug/NN store/NN and/CC buy/VB the/DT drug/NN and/CC start/VB popping/VBG it/PRP ,/, ''/'' she/PRP said/VBD ./.

Part/NN of/IN the/DT lung/NN damage/NN that/WDT occurs/VBZ in/IN cystic/JJ fibrosis/NNS is/VBZ caused/VBN by/IN inflammation/NN of/IN the/DT lungs/NNS ./.

Ibuprofen/NN ,/, an/DT anti-inflammatory/NN ,/, helps/VBZ to/TO control/VB that/DT ./.

Cystic/JJ fibrosis/NNS is/VBZ the/DT most/RBS common/JJ fatal/JJ inherited/VBN disease/NN of/IN Americans/NNPS ./.

About/RB 30,000/CD Americans/NNS ,/, mostly/RB whites/NNS ,/, are/VBP afflicted/VBN with/IN the/DT disease/NN ,/, and/CC one/CD in/IN 25/CD white/JJ Americans/NNS is/VBZ a/DT carrier/NN of/IN the/DT CF/NNP gene/NN ./.

The/DT disease/NN occurs/VBZ only/RB in/IN those/DT who/WP get/VBP two/CD copies/NNS of/IN the/DT gene/NN ,/, one/CD from/IN each/DT parent/NN ./.

Davis/NNP and/CC her/PRP$ colleagues/NNS studied/VBD 85/CD patients/NNS ages/CD 5/CD to/TO 39/CD ./.

Some/DT were/VBD given/VBN ibuprofen/NN and/CC some/DT were/VBD given/VBN placebo/NN for/IN a/DT period/NN of/IN four/CD years/NNS ./.

Doses/NNS were/VBD adjusted/VBN individually/RB ,/, with/IN some/DT patients/NNS taking/VBG the/DT equivalent/NN of/IN 16/CD over-the-counter/JJ tablets/NNS a/DT day/NN ./.

The/DT recommended/VBN dose/NN is/VBZ normally/RB one/CD or/CC two/CD tablets/NNS every/DT four/CD to/TO six/CD hours/NNS ,/, with/IN a/DT maximum/NN of/IN six/CD tablets/NNS in/IN 24/CD hours/NNS ./.

In/IN a/DT standard/JJ measure/NN of/IN lung/NN function/NN in/IN which/WDT patients/NNS are/VBP asked/VBN to/TO exhale/VB as/RB quickly/RB as/IN they/PRP can/MD ,/, the/DT researchers/NNS saw/VBD a/DT 16/CD percent/NN decline/NN in/IN the/DT placebo/NN group/NN over/IN the/DT four/CD years/NNS ,/, compared/VBN with/IN only/RB a/DT 2/CD percent/NN decline/NN in/IN the/DT members/NNS of/IN the/DT ibuprofen/JJ group/NN ages/NNS 5/CD to/TO 13/CD who/WP took/VBD their/PRP$ medication/NN consistently/RB ./.

That/DT represents/VBZ a/DT slowing/NN of/IN 90/CD percent/NN in/IN lung/NN deterioration/NN ,/, she/PRP said/VBD ./.

The/DT numbers/NNS were/VBD corrected/VBN to/TO allow/VB for/IN growth/NN of/IN the/DT children/NNS during/IN the/DT time/NN they/PRP were/VBD studied/VBN ,/, she/PRP said/VBD ./.

